Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma

Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma

Item
http://www.wikidata.org/entity/Q27015903
MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell linesNovel therapeutic combination demonstrates more than additive effects in cutaneous T-cell lymphoma.Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients.The biomarker landscape in mycosis fungoides and Sézary syndrome.Genomic landscape of cutaneous T cell lymphoma.Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progressionONC201 selectively induces apoptosis in cutaneous T-cell lymphoma cells via activating pro-apoptotic integrated stress response and inactivating JAK/STAT and NF-κB pathways.Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
P2860

Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma

Item
http://www.wikidata.org/entity/Q27015903
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@ast
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@en
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@nl
type
label
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@ast
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@en
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@nl
prefLabel
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@ast
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@en
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma
@en
P2093
P304
P31
P407
P433
P478
P577
P698
P921